← Open Payments lookup

KYLE NEWMAN: Open Payments

NPI 1467796185 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$641 in 43 payments from 9 companies in 2025. Trend: 2023 $301 · 2024 $1,248 · 2025 $641

Food & beverage: $641
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.14$178
ABBVIE INC.14$150
Axsome Therapeutics, Inc.6$147
Neuronetics, Inc.2$47
Alkermes, Inc.2$35
Otsuka America Pharmaceutical, Inc.2$33
Neurocrine BioSciences, Inc.1$21
Teva Pharmaceuticals USA, Inc.1$17
Lundbeck LLC1$14

Products named: COBENFY, VRAYLAR, Auvelity, NEUROSTAR TMS THERAPY SYSTEM, LYBALVI, ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR.

Industry payments across UT — which companies pay providers there.